MUMBAI, India, April 17 -- Intellectual Property India has published a patent application (202641020804 A) filed by Saveetha Institute Of Medical And Technical Sciences, Chennai, Tamil Nadu, on Feb. 23, for 'diabel fioravita.'
Inventor(s) include Afrin K; Dr. M. Mugilan; and Deepak Nallaswamy Veeraiyan.
The application for the patent was published on April 17, under issue no. 16/2026.
According to the abstract released by the Intellectual Property India: "The present study focuses on the development of Diabel Fioravita, a natural herbal powder formulation prepared from Avaram poo, Guava leaves, Insulin leaves, and Paneer poo for diabetic patient support. The formulation is designed to provide a safe, cost-effective nutraceutical supplement that helps regulate blood glucose levels while offering antioxidant, anti-inflammatory, and metabolic health benefits. Fresh herbal ingredients are processed under controlled hygienic conditions, dehydrated, and converted into fine powder to retain essential nutrients and bioactive compounds. The blend is formulated in optimized proportions to ensure therapeutic effectiveness, safety, palatability, and patient acceptability. Special emphasis is given to achieving long-term stability of up to 1.5 years through controlled moisture reduction, microbial safety, and protective packaging. The product is preservative free, natural, portable, and suitable for clinical, hospital, and home-care use. By utilizing herbal ingredients with beneficial anti-diabetic properties, Diabel Fioravita supports improved diabetic health management while maintaining quality, safety, and extended shelflife."
Disclaimer: Curated by HT Syndication.
